Angelor
Impact investorSeed–Series A · 6 people tracked
Find your way into Angelor
Sign up to see every warm intro you have to Angelor
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Angelor team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Angelor invests in and supports French healthcare scaleups, backing innovations from spin-off stage through Series A that have demonstrated both medical and economic potential. The firm provides capital along with business and health-sector expertise, acting as a sparring partner to companies and their leaders with the help of an active community of experienced investors and entrepreneurs. Its goal is to accelerate the clinical, industrial and commercial scale-up of innovations that can make a difference to patient health within five years, unifying economic performance with medical progress. As a mission-driven company, Angelor also commits roughly 10% of its carried interest to health-related associations.
Source: firm website, verified Sep 27, 2026.
Team · 6 people
from the firm's websiteWhat they invest in
from 2 of 2 portfolio companiesClimate Tech ×2FoodTech ×2AgTech ×1Biotech ×1Deep Tech ×1New Materials ×1
HQs:France×2
Investments · 2 tracked
founders shown can be your intro pathnextProtein breeds Black Soldier Fly larvae on unconsumed food to produce insect-based protein, oil and fertilizer used as ingredients in animal feed for aquaculture, poultry, pork and pet food.
AgTechClimate TechFoodTechParis, FR
Syrine Chaalala(Co-founder)inMohamed Gastli(Co-founder)in
Co-investorsKima VenturesAnaxagoBritish International InvestmentMirovaRAISE
Standing Ovation produces animal-free casein, the main protein in milk, using a patented process that replicates the structure and amino acid sequence of cow, goat, or sheep casein without livestock farming.
BiotechClimate TechDeep TechFoodTechNew Materials
Romain Chayot(Co-founder, Board Member & President)in
Co-investorsAstanor VenturesBig Idea VenturesSeventure PartnersBpifrancePeakBridge VC
Portfolio news
latest coverage across their companiesFrequently asked questions
- What stage does Angelor invest at?
- Angelor invests at the Seed, Series A stages.
- What sectors does Angelor focus on?
- Angelor focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
Similar investors
Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Lerer Hippeau is an early-stage venture capital firm that backs founders across sectors, emphasizing investing in companies before they gain wider recognition.
Cancer Fund is an early-stage oncology venture capital and venture-giving organization that funds diagnostics, therapeutics, and other cancer-targeting innovations, offering both charitable donation and accredited-investor pathways.
Global Health Investment Corporation (GHIC) is a nonprofit that invests in life sciences and healthcare technology companies to accelerate the development and accessibility of products improving global public health and health equity.



















